Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles

Jen Mains, Dimitrios Lamprou, Lisa McIntosh, Iain Oswald, Andrew Urquhart

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)


Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.
Original languageEnglish
Pages (from-to)5082-5084
Number of pages3
JournalJournal of the Chemical Society, Chemical Communications
Issue number44
Early online date23 Apr 2013
Publication statusPublished - 4 Jun 2013


  • beta-adrenoceptor antagonists
  • amyloid nanostructure
  • drug delivery vehicles
  • amyloid hydrogels

Cite this